SOUTH SAN FRANCISCO, Calif., Feb. 21, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at four investor conferences in February and March.
2012 Citi Global Healthcare Conference
Onyx will present at the 2012 Citi Global Healthcare Conference on Monday, February 27, 2012 at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time).
Cowen and Company 32nd Annual Health Care Conference
Onyx will present at the Cowen and Company 32nd Annual Health Care Conference on Wednesday, March 7, 2012 at 9:20 a.m. Eastern Time (6:20 a.m. Pacific Time).
24th Annual ROTH Conference
Onyx will present at the 24th Annual ROTH Conference on Monday, March 12, 2012 at 11:30 a.m. Eastern Time (8:30 a.m. Pacific Time).
Barclays Capital Global Healthcare Conference
Onyx will present at the Barclays Capital Global Healthcare Conference on Tuesday, March 13, 2012 at 9:30 a.m. Eastern Time (6:30 a.m. Pacific Time).
Interested parties may access a live webcast of the presentation on our website at:
http://www.onyx.com/investors/event-calendar
It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through the following dates:
- 2012 Citi Global Healthcare Conference - March 12, 2012
- Cowen and Company 32nd Annual Health Care Conference - March 21, 2012
- 24th Annual ROTH Conference March 26, 2012
- Barclays Capital Global Healthcare Conference March 27, 2012
About Onyx Pharmaceuticals, Inc.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company’s website at www.onyx.com.
SOURCE Onyx Pharmaceuticals, Inc.
